| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/18/2004 | CN1138563C Vector for diagnosis and treatment of solid tumors including melanoma |
| 02/18/2004 | CN1138560C Method for control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 02/18/2004 | CN1138551C Eipthelial adhesive lactobacilli |
| 02/18/2004 | CN1138550C Process of producing extracts of shark |
| 02/18/2004 | CN1138549C Mampalon perfume and its producing method |
| 02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 02/18/2004 | CN1138545C Use of penciclovir for treatment of human herpes-virus-8 |
| 02/18/2004 | CN1138538C Antiviral agents |
| 02/18/2004 | CN1138533C Liposomes |
| 02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
| 02/17/2004 | US6693193 Coupling an n- and o-protected 2,3-dihydroxy-pyrrolidine to the 2-position and deprotecting |
| 02/17/2004 | US6693186 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 02/17/2004 | US6693167 Peptide-based gemini compounds |
| 02/17/2004 | US6693118 E.G., 1-(2-(6,7-METHYLENEDIOXYNAPHTH-2-YL)-ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE AND 1-2-(4-CYCLOHEXENYLPHENYL)-ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6 -TETRAHYDROPYRIDINE; apoptosis inhibition; treatment of graft rejection or of acute or chronic rheumatoid arthritis |
| 02/17/2004 | US6693114 N-(4-chlorobenzyl)-6-(3-hydroxy-1-propynyl)-1-7-dimethyl-4-oxo-1,4 -dihydro(1,8) naphthyridine-3-carboxamide for example; inhibiting viral dna polymerase; treating herpes virus infections |
| 02/17/2004 | US6693113 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections |
| 02/17/2004 | US6693112 Compounds for enhancing chemotherapy |
| 02/17/2004 | US6693108 Pyrimidinyl-guanidine derivatives |
| 02/17/2004 | US6693102 Pyridine-substituted pyrazolopyridine derivatives |
| 02/17/2004 | US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| 02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 02/17/2004 | US6693096 Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors |
| 02/17/2004 | US6693095 7-(((5-amino-1,2,4-thiadiazol-3-yl)-(z)-(fluormethoxyimino) -acetyl)amino)-3(e)-((imino-1-piperazinylmethyl)-methylhydrazono)methyl-3 -cephem-4-carboxylic acid trihydrochloride for example |
| 02/17/2004 | US6693085 Has an activity against mrsa (methicillin-resistant staphylococcus aureus). |
| 02/17/2004 | US6692958 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations |
| 02/17/2004 | US6692956 Recombinant adenoviral vectors |
| 02/17/2004 | US6692950 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid |
| 02/17/2004 | US6692943 Persephin and related growth factors |
| 02/17/2004 | US6692907 Conserved motif of hepatitis C virus E2/NS1 region |
| 02/17/2004 | US6692753 Potentiation of the immune response |
| 02/17/2004 | US6692750 Introducing into cells recombinant alphavirus rna genome and helper rna encoding alphavirus structural proteins, including coding sequences for proteins and cis acting replication signals; incubating to produce infectious virus particles |
| 02/17/2004 | US6692747 Peptide for use in the treatment of infections, viral and cancer diseases |
| 02/17/2004 | US6692735 Truncated variant of c6 beta-chemokine leukotactin-1 polypeptide consisting of specified amino acid sequence |
| 02/17/2004 | CA2293823C 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 02/17/2004 | CA2268908C Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 02/12/2004 | WO2004013342A1 NOVEL SUBSTANCES PF1237A, B and M EXHIBITING ANTIFUNGAL ACTIVITY |
| 02/12/2004 | WO2004013310A2 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 02/12/2004 | WO2004013300A2 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 02/12/2004 | WO2004013165A1 Pegylated t1249 polypeptide |
| 02/12/2004 | WO2004013164A1 Pegylated t20 polypeptide |
| 02/12/2004 | WO2004013151A2 Campylobacter glycans and glycopeptides |
| 02/12/2004 | WO2004013146A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 02/12/2004 | WO2004013144A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | WO2004013138A2 Imidazo`1,2-a!pyridines |
| 02/12/2004 | WO2004013130A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | WO2004013125A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 02/12/2004 | WO2004013117A1 Bicyclic cylopentanone and cyclopentenone derivatives as potent activators of hsf |
| 02/12/2004 | WO2004013110A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazoliniones useful as hiv reverse transcriptase inhibitors |
| 02/12/2004 | WO2004013109A1 Resorcinol derivative |
| 02/12/2004 | WO2004013093A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/12/2004 | WO2004013077A2 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 02/12/2004 | WO2004012816A1 Antibacterial ester macrocycles |
| 02/12/2004 | WO2004012739A1 Novel crystalline forms of gatifloxacin |
| 02/12/2004 | WO2004012713A1 Delayed release anti-viral product, use and formulation thereof |
| 02/12/2004 | WO2004012659A2 Nitrosated proton pump inhibitors, compositions and methods of use |
| 02/12/2004 | WO2004012655A2 Anti-microbial compositions and methods of using same |
| 02/12/2004 | WO2004012653A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 02/12/2004 | WO2004012651A2 Composition for heart disease, method to prepare same and uses thereof |
| 02/12/2004 | WO2003097582A3 Synthesis of benzonitriles and benzimidates |
| 02/12/2004 | WO2003094963A3 Methylated immunostimulatory oligonucleotides and methods of using the same |
| 02/12/2004 | WO2003093462A3 Immobilisation and stabilisation of virus |
| 02/12/2004 | WO2003091259A8 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 02/12/2004 | WO2003090672A3 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/12/2004 | WO2003086417B1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 02/12/2004 | WO2003077882A3 Preparation of sterile stabilized nanodispersions |
| 02/12/2004 | WO2003072789A3 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 02/12/2004 | WO2003070968A3 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/12/2004 | WO2003070236A3 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2003070171A9 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 02/12/2004 | WO2003064453A3 Trojan inhibitors, method for the production and use thereof |
| 02/12/2004 | WO2003060142A3 Compositions and methods for controlled release |
| 02/12/2004 | WO2003049723A3 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | WO2003044524A3 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 02/12/2004 | WO2003037916A3 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/12/2004 | WO2003035012A3 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 02/12/2004 | WO2003033653B1 Affinity enhancement agents |
| 02/12/2004 | WO2003022225A3 Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
| 02/12/2004 | WO2003013424A3 Use of r-nsaid compounds for anti-hiv treatment |
| 02/12/2004 | WO2003010159A8 Piperidine derivatives as nmda receptor antagonists |
| 02/12/2004 | WO2003008365A3 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2002100330A3 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 02/12/2004 | WO2002076507A3 Uses of opg ligand to modulate immune responses |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | WO2002054931A3 Alpha-aminoboronic acids prepared by novel synthetic methods |
| 02/12/2004 | WO2002035981A3 Methods and compositions for the treatment of human immunodeficiency virus infection |
| 02/12/2004 | US20040030096 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 02/12/2004 | US20040029947 R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease |
| 02/12/2004 | US20040029939 Inhibitors of IMPDH enzyme |
| 02/12/2004 | US20040029938 Medicaments |
| 02/12/2004 | US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/12/2004 | US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/12/2004 | US20040029928 Tumor necrosis factor alpha-converting enzyme inhibitor; rheumatic diseases; antiarthritic agents; infections; autoimmune diseases; antidiabetic agents |
| 02/12/2004 | US20040029918 Bactericides; termite extract |
| 02/12/2004 | US20040029916 Antiarthritic agents; skin disorders; Crohn's disease |
| 02/12/2004 | US20040029915 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 02/12/2004 | US20040029910 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
| 02/12/2004 | US20040029908 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 02/12/2004 | US20040029892 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses |